carbon tetrachloride has been researched along with largazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Friedman, SL; Ji, L; Kwong, S; Lam, W; Li, F; Liu, Y; Lui, EL; Ren, Q; Tang, S; Wang, J; Wang, X; Wang, Z; Xu, Z; Ye, T; Zhang, H; Zhou, S | 1 |
1 other study(ies) available for carbon tetrachloride and largazole
Article | Year |
---|---|
A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
Topics: Acetylation; Angiogenesis Inhibitors; Animals; Apoptosis; Carbon Tetrachloride; Cell Line; Depsipeptides; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Liver; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred BALB C; Neovascularization, Physiologic; Rats; RNA Interference; Signal Transduction; Thiazoles; Time Factors; Transfection; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2013 |